Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 65

1.

Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.

Ramasamy S, Liu CQ, Tran H, Gubala A, Gauci P, McAllister J, Vo T.

Br J Pharmacol. 2010 Oct;161(4):721-48. doi: 10.1111/j.1476-5381.2010.00939.x. Review.

PMID:
20860656
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Current therapy and the development of therapeutic options for the treatment of diseases due to bacterial agents of potential biowarfare and bioterrorism.

Greenfield RA, Bronze MS.

Curr Opin Investig Drugs. 2004 Feb;5(2):135-40. Review.

PMID:
15043386
[PubMed - indexed for MEDLINE]
3.

Biological and chemical terrorism: recognition and management.

Noeller TP.

Cleve Clin J Med. 2001 Dec;68(12):1001-2, 1004-9, 1013-6. Review.

PMID:
11765118
[PubMed - indexed for MEDLINE]
Free Article
4.

Research strategies for the treatment of biothreats.

Cherwonogrodzky JW.

Curr Opin Pharmacol. 2005 Oct;5(5):465-72. Review.

PMID:
16084772
[PubMed - indexed for MEDLINE]
5.

Biological and chemical agents: a brief synopsis.

Rosenbloom M, Leikin JB, Vogel SN, Chaudry ZA.

Am J Ther. 2002 Jan-Feb;9(1):5-14. Review.

PMID:
11782813
[PubMed - indexed for MEDLINE]
6.

Vaccines against biologic agents: uses and developments.

Ales NC, Katial RK.

Respir Care Clin N Am. 2004 Mar;10(1):123-46. Review.

PMID:
15062232
[PubMed - indexed for MEDLINE]
7.

Bacterial agents used for bioterrorism.

Horn JK.

Surg Infect (Larchmt). 2003 Fall;4(3):281-7. Review.

PMID:
14588163
[PubMed - indexed for MEDLINE]
8.

Vaccines and bioterrorism: smallpox and anthrax.

Kimmel SR, Mahoney MC, Zimmerman RK.

J Fam Pract. 2003 Jan;52(1 Suppl):S56-61. Review.

PMID:
12556279
[PubMed - indexed for MEDLINE]
9.

Anthrax as a biological weapon, 2002: updated recommendations for management.

Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Gerberding J, Hauer J, Hughes J, McDade J, Osterholm MT, Parker G, Perl TM, Russell PK, Tonat K; Working Group on Civilian Biodefense.

JAMA. 2002 May 1;287(17):2236-52. Review. Erratum in: JAMA 2002 Oct 16;288(15):1849.

PMID:
11980524
[PubMed - indexed for MEDLINE]
10.

Clinical recognition and management of patients exposed to biological warfare agents.

Franz DR, Jahrling PB, Friedlander AM, McClain DJ, Hoover DL, Bryne WR, Pavlin JA, Christopher GW, Eitzen EM Jr.

JAMA. 1997 Aug 6;278(5):399-411. Review.

PMID:
9244332
[PubMed - indexed for MEDLINE]
11.

[Anthrax--an overview at 2002].

Mozes YN, Winder A, Tadmor B, Rotman E, Sagi R, Hourvitz A.

Harefuah. 2002 May;141 Spec No:63-72, 121, 120. Review. Hebrew.

PMID:
12170557
[PubMed - indexed for MEDLINE]
12.

Biological agents: weapons of warfare and bioterrorism.

Broussard LA.

Mol Diagn. 2001 Dec;6(4):323-33. Review.

PMID:
11774197
[PubMed - indexed for MEDLINE]
13.

Issues in preparedness for biologic terrorism: a perspective for critical care nursing.

O'Connell KP, Menuey BC, Foster D.

AACN Clin Issues. 2002 Aug;13(3):452-69. Review.

PMID:
12151997
[PubMed - indexed for MEDLINE]
14.

Overview: cause and prevention in biowarfare and bioterrorism.

Hilleman MR.

Vaccine. 2002 Aug 19;20(25-26):3055-67. Review.

PMID:
12163257
[PubMed - indexed for MEDLINE]
15.

Bioterrorism: a new frontier for drug discovery and development.

Shailubhai K.

IDrugs. 2003 Aug;6(8):773-80. Review.

PMID:
12917773
[PubMed - indexed for MEDLINE]
16.

The threat of biological terrorism: a public health and infection control reality.

Leggiadro RJ.

Infect Control Hosp Epidemiol. 2000 Jan;21(1):53-6. Review.

PMID:
10656359
[PubMed - indexed for MEDLINE]
17.

Passive antibody administration (immediate immunity) as a specific defense against biological weapons.

Casadevall A.

Emerg Infect Dis. 2002 Aug;8(8):833-41. Review.

PMID:
12141970
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Ricin vaccine development.

Smallshaw JE, Vitetta ES.

Curr Top Microbiol Immunol. 2012;357:259-72. doi: 10.1007/82_2011_156. Review.

PMID:
21805396
[PubMed - indexed for MEDLINE]
19.

Medical management of biological warfare and bioterrorism: place of the immunoprevention and the immunotherapy.

Binder P, Attre O, Boutin JP, Cavallo JD, Debord T, Jouan A, Vidal D.

Comp Immunol Microbiol Infect Dis. 2003 Oct;26(5-6):401-21. Review.

PMID:
12818625
[PubMed - indexed for MEDLINE]
20.

Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents.

Brouillard JE, Terriff CM, Tofan A, Garrison MW.

Pharmacotherapy. 2006 Jan;26(1):3-14. Review.

PMID:
16506347
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk